Avantor® Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry
Avantor, Inc. (NYSE: AVTR) announced on May 5, 2022, the establishment of a new manufacturing and distribution hub in Singapore. This hub aims to enhance supply chain capabilities and better serve the burgeoning Asia Pacific Biopharma market. Integrating existing facilities with new manufacturing operations, the hub will boost regional innovation and deliver services such as quality control and testing labs, becoming operational early next year. This strategic move highlights Avantor's commitment to expanding in Asia and improving lead times and supply chain security.
- Establishment of a manufacturing and distribution hub to enhance supply chain capabilities.
- Integration of existing distribution facility with new manufacturing operations to better serve the Asia Pacific Biopharma market.
- Expected operational status by early next year, improving service lead times and supply chain security.
- None.
SINGAPORE, May 5, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced it will create a new manufacturing and distribution hub in Singapore by integrating its existing distribution facility with new manufacturing operations. The new hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year.
"The Singapore Manufacturing and Distribution Hub will enable Avantor to better serve the fast-growing Asia Pacific Biopharma market by facilitating shorter lead times, enhancing supply chain security and increasing capacity in the region," said Christophe Couturier, Executive Vice President, AMEA, Avantor. "The hub will boost regional innovation and serve as an industry benchmark for Singapore and Asia Pacific's global quality and regulatory standards, and demonstrates Avantor's commitment to growing our presence in the region."
The new hub will provide a range of services including quality control and inventory management expertise, and feature cGMP manufacturing suites and testing labs for process ingredients and excipients.
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, visit avantorsciences.com and find us on LinkedIn, Twitter and Facebook.
Regional Media Contact
Christina Koh
Director, Communications - AMEA
Avantor
M: +65 9720 0169
Christina.Koh@avantorsciences.com
Global Media Contact
Petro Kacur
Director, PR & External Communications
Avantor
M: +1 404-408-0663
petro.kacur@avantorsciences.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/avantor-announces-investment-in-manufacturing-and-distribution-hub-in-singapore-to-serve-rapidly-growing-asia-pacific-biopharma-industry-301540014.html
SOURCE Avantor and Financial News
FAQ
What is Avantor's recent announcement regarding a manufacturing hub in Singapore?
When will Avantor's Singapore hub be operational?
How will the new hub benefit Avantor's operations?
What services will be offered at Avantor's new hub in Singapore?
